StockData
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Pharvaris N.V.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026
$29.77+2.03 (+7.32%)

Close on Oct 19, 2026

Pharvaris N.V. revenue by segment

No segment breakdown reported

Pharvaris does not break out revenue by segment, region or product in the tagged data of its filings for this period type.